Market closed
Hoth Therapeutics Inc./$HOTH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
Ticker
$HOTH
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
3
Website
HOTH Metrics
BasicAdvanced
$10M
-
-$1.28
0.64
-
Price and volume
Market cap
$10M
Beta
0.64
52-week high
$1.29
52-week low
$0.66
Average daily volume
599K
Financial strength
Current ratio
9.197
Quick ratio
8.525
Long term debt to equity
0.039
Total debt to equity
0.452
Management effectiveness
Return on assets (TTM)
-57.19%
Return on equity (TTM)
-99.75%
Valuation
Price to book
0.9
Price to tangible book (TTM)
0.9
Price to free cash flow (TTM)
-0.707
Growth
Earnings per share change (TTM)
-45.98%
3-year earnings per share growth (CAGR)
-56.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Hoth Therapeutics Inc. stock?
Hoth Therapeutics Inc. (HOTH) has a market cap of $10M as of April 17, 2025.
What is the P/E ratio for Hoth Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Hoth Therapeutics Inc. (HOTH) stock is 0 as of April 17, 2025.
Does Hoth Therapeutics Inc. stock pay dividends?
No, Hoth Therapeutics Inc. (HOTH) stock does not pay dividends to its shareholders as of April 17, 2025.
When is the next Hoth Therapeutics Inc. dividend payment date?
Hoth Therapeutics Inc. (HOTH) stock does not pay dividends to its shareholders.
What is the beta indicator for Hoth Therapeutics Inc.?
Hoth Therapeutics Inc. (HOTH) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.